Telegram
NASDAQ: LYEL - Lyell Immunopharma, Inc.
Доходность за полгода: -6%
Сектор: Healthcare
| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E |
|
-2.4 | 47.96 | -105% | 3.73 | -164.26% |
P/E Forward 
|
|
-2.8 | 3.73 | -175.13% | ||
| P/S |
|
4325.38 | 33.73 | 12724.73% | 1434.06 | 201.62% |
| P/S Forward |
|
0 | 1434.06 | -100% | ||
| P/BV |
|
0.8634 | 4.81 | -82.04% | 1.1802 | -26.85% |
| P/BV Forward |
|
1.2298 | 1.1802 | 4.2% | ||
| Ev/Ebitda |
|
-2.11 | -22.5 | -90.6% | -1.9034 | 11.1% |
| Ev/Ebitda Forward |
|
-2.08 | -1.9034 | 9.49% |
